NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free CPIX Stock Alerts $1.51 +0.09 (+6.34%) (As of 01:44 PM ET) Add Compare Share Share Today's Range$1.42▼$1.5150-Day Range$1.42▼$2.2152-Week Range$1.42▼$2.36Volume7,934 shsAverage Volume11,257 shsMarket Capitalization$21.41 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Cumberland Pharmaceuticals alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.Read More CPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPIX Stock News HeadlinesMay 2, 2024 | msn.comCumberland County man convicted of January 6 felonies identified by dating websiteMay 2, 2024 | americanbankingnews.comStockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX)May 2, 2024 | Stansberry Research (Ad)Urgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.May 2, 2024 | sports.yahoo.comCumberland plays Lindsey Wilson again today in play-in gameMay 2, 2024 | msn.comCoffee shop in Cumberland County that employs sex trafficking survivors to hold grand openingMay 1, 2024 | msn.comTwo Cumberland County men charged with drug trafficking, illegally possessing firearmsMay 1, 2024 | msn.comNorth Yarmouth Academy students root for Cumberland singer vying to become next American IdolMay 1, 2024 | msn.comCumberland Valley boys lacrosse defeats Red Land, 12-11May 2, 2024 | Stansberry Research (Ad)Urgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.May 1, 2024 | msn.comHere are the hours, locations and times for Cumberland County pools and splash padsMay 1, 2024 | msn.comCumberland County’s top rated schools. See latest full list.May 1, 2024 | nj.comFiorani powers Cumberland in slugfest with Deptford - baseball recapMay 1, 2024 | nj.comEdminster home run lifts Cumberland over Deptford - softball recapApril 30, 2024 | prnewswire.comCUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTSApril 30, 2024 | news.yahoo.comMan accused of trying to 'buy a child' booked into Cumberland County jailApril 30, 2024 | msn.comSanford man charged with human trafficking held on $3M bond in Cumberland County, deputies sayApril 30, 2024 | msn.comTraffic Alert: Crash closes busy road in Cumberland CountyApril 30, 2024 | nj.comRosas drives in four as Gloucester Tech rallies by Cumberland -baseball recapApril 29, 2024 | yahoo.com1 displaced after house fire in Cumberland CountyApril 29, 2024 | msn.comMan facing manslaughter charges in Cumberland County fatal stabbing turns himself inApril 29, 2024 | msn.comArrest made in deadly stabbing at Cumberland County sports barApril 29, 2024 | msn.comCumberland restaurant given new five-star food hygiene ratingApril 29, 2024 | msn.com1 person displaced after house fire in Cumberland CountyApril 29, 2024 | news.yahoo.comWanted man jumps into Cumberland River after spotted by Metro policeApril 28, 2024 | msn.comRoad restrictions planned for I-83 in Cumberland and Dauphin countiesApril 28, 2024 | msn.com7-year-old Cumberland girl becomes CEO of "Unicorn World" for a dayApril 28, 2024 | msn.comOne in seven Cumberland households in fuel povertySee More Headlines Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/05/2024Today5/02/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees91Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,280,000.00 Net Margins-15.87% Pretax Margin-15.89% Return on Equity6.84% Return on Assets2.70% Debt Debt-to-Equity Ratio0.44 Current Ratio1.28 Quick Ratio1.11 Sales & Book Value Annual Sales$39.55 million Price / Sales0.53 Cash Flow$0.65 per share Price / Cash Flow2.31 Book Value$1.96 per share Price / Book0.76Miscellaneous Outstanding Shares14,180,000Free Float8,038,000Market Cap$21.13 million OptionableOptionable Beta0.17 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. A. J. Kazimi MBA (Age 66)Founder, Chairman, President & CEO Comp: $952.53kMr. John Michael Hamm (Age 68)VP & CFO Comp: $258.38kMr. James Lowrance Herman (Age 69)Executive VP of National Accounts & Chief Compliance Officer Comp: $372.27kMr. Chris T. Bitterman (Age 59)Vice President of Sales & Marketing Comp: $290.87kMr. Todd M. Anthony (Age 63)Vice President of Organizational Development Comp: $304.94kMs. Jean W. Marstiller (Age 74)Senior VP of Administrative Services & Corporate Secretary Comp: $282.17kMr. Adam S. Mostafa (Age 44)Managing Director Ms. Erin Smith GullSenior Corporate Relations AssociateMore ExecutivesKey CompetitorsAssembly BiosciencesNASDAQ:ASMBLisata TherapeuticsNASDAQ:LSTAOncternal TherapeuticsNASDAQ:ONCTCytoMed TherapeuticsNASDAQ:GDTCLumos PharmaNASDAQ:LUMOView All CompetitorsInstitutional OwnershipSimplex Trading LLCBought 300 shares on 2/2/2024Ownership: 0.000%View All Institutional Transactions CPIX Stock Analysis - Frequently Asked Questions How have CPIX shares performed in 2024? Cumberland Pharmaceuticals' stock was trading at $1.7917 at the beginning of 2024. Since then, CPIX stock has decreased by 15.7% and is now trading at $1.51. View the best growth stocks for 2024 here. Are investors shorting Cumberland Pharmaceuticals? Cumberland Pharmaceuticals saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 17,000 shares, a drop of 16.7% from the March 15th total of 20,400 shares. Based on an average trading volume of 11,800 shares, the short-interest ratio is currently 1.4 days. Approximately 0.2% of the shares of the stock are short sold. View Cumberland Pharmaceuticals' Short Interest. When is Cumberland Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our CPIX earnings forecast. How can I listen to Cumberland Pharmaceuticals' earnings call? Cumberland Pharmaceuticals will be holding an earnings conference call on Tuesday, May 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced its earnings results on Tuesday, March, 5th. The specialty pharmaceutical company reported ($0.12) EPS for the quarter. The specialty pharmaceutical company earned $9.35 million during the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 6.84% and a negative net margin of 15.87%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS). Who are Cumberland Pharmaceuticals' major shareholders? Cumberland Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas. View institutional ownership trends. How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CPIX) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingA once-in-a-century investment opportunityStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.